Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Luba Trakhtenbrot, PhD, Adrian Duek, MD, Ninette Amariglio, PhD, Abraham Avigdor, MD, Noam Benyamini, MD, Izhar Hardan, MD, Itay Zilbershatz, MD, Chezi Ganzel, MD, Olga Shvetz, MD, Ronit Leiba, PhD, Marina Izak, MD, Cohen Ziv, Ba, Gabriela Rozic, PhD, Arnon Nagler, MD, Merav Leiba

Blood (2017) 130 (Supplement 1): 5368.

https://doi.org/10.1182/blood.V130.Suppl_1.5368.5368

Published: 2017

Journal Articles

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Eldad J Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Elinor Sabbag, BSc., Marina Izak, MD, Abraham Korenberg, MD, Luiza Akria, MD, Dina Attias, MD, Kalman Filanovsky, MD, Uri Abadi, MD, Rosa Ruchlemer, MD, Roxolyana Abdah-Bortnyak, MD, Neta Goldschmidt, MD, Ron Epelbaum, MD, Netanel Horowitz, David Lavie, MD, Dina Ben Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MDM, MSc

Blood (2014) 124 (21): 4409.

https://doi.org/10.1182/blood.V124.21.4409.4409

Published: 2014

Journal Articles

Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b

Alexandra Kruse, Alexa M. Sughroue, Patrick Morrissey, Claudia Tchatchouang, M.A., Guangheng Zhu, MD, Marina Izak, MD, Heyu Ni, MD PhD, James B. Bussel, MD

Blood (2014) 124 (21): 4190.

https://doi.org/10.1182/blood.V124.21.4190.4190

Published: 2014

Journal Articles

Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture

Marina Izak, MD, Mauro Avanzi, MD PhD, Yaffa Bareli, James B. Bussel, MD, W. Beau Mitchell, MD

Blood (2014) 124 (21): 5114.

https://doi.org/10.1182/blood.V124.21.5114.5114

Published: 2014

Journal Articles

Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Abraham Kornberg, MD, Marina Izak, MD, Yossi Cohen, MD, BsC

Blood (2013) 122 (21): 3628.

https://doi.org/10.1182/blood.V122.21.3628.3628

Published: 2013

Journal Articles

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Eldad J. Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Marina Izak, MD, Abraham Korenberg, MD, Luiza Akria, MD, Dina Attias, MD, Kalman Filanovsky, MD, Liana Abdach, MD, Neta Goldschmidt, MD, Ron Epelbaum, MD, Jacob M. Rowe, MD, Dina Ben Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MSc, FRCPC

Blood (2010) 116 (21): 2809.

https://doi.org/10.1182/blood.V116.21.2809.2809

Published: 2010

NARROW

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b

Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture

Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Email alerts

ASH Publications

American Society of Hematology

Monoallelic Deletion of the Whole Locus of Immunoglobulin Heavy Chain Gene [Del(IGH)] Is Associated with a Better Prognosis in Newly Diagnosed Multiple Myeloma

Tailored Therapy in Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT: Israeli H2 Study

Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b

Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture

Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Tailored Therapy In Hodgkin Lymphoma, Based on Predefined Risk Factors and Early Interim PET/CT, Can Lead to Modification and Safe Reduction In Therapy: Results of 134 Patients on the Israel National Hodgkin Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only